AIM ImmunoTech Inc. (AIM)
NYSE · Healthcare
AIM ImmunoTech Inc. Operating Income 2009–2025
AIM ImmunoTech Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- AIM ImmunoTech Inc. operating income for the quarter ending March 31, 2026 was -2.2 M, a 38.49% decrease year-over-year.
- AIM ImmunoTech Inc. operating income for the twelve months ending March 31, 2026 was -10.9 M, a 50.45% decrease year-over-year.
- AIM ImmunoTech Inc. annual operating income for 2025 was -11.7 M, a 41.01% decrease from 2024.
- AIM ImmunoTech Inc. annual operating income for 2024 was -19.8 M, a 38.05% decrease from 2023.
- AIM ImmunoTech Inc. annual operating income for 2023 was -31.9 M, a 60.20% increase from 2022.
- AIM ImmunoTech Inc. annual operating income for 2022 was -19.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
AIM ImmunoTech Inc. Operating Income — FAQ
AIM ImmunoTech Inc. (AIM) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is AIM ImmunoTech Inc.'s operating income?
AIM ImmunoTech Inc. (AIM) reported operating income of -$12M for fiscal 2025.
Where can I see AIM's operating income history?
The chart and table above show AIM ImmunoTech Inc.'s operating income by year and by quarter, including the growth rate.